Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 2
2017 3
2018 3
2019 3
2020 4
2021 3
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Au@109Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of 109Pd/109mAg in vivo generator in combined β- auger electron therapy.
Gharibkandi NA, Wawrowicz K, Majkowska-Pilip A, Żelechowska-Matysiak K, Wierzbicki M, Bilewicz A. Gharibkandi NA, et al. Among authors: majkowska pilip a. EJNMMI Radiopharm Chem. 2023 Oct 11;8(1):26. doi: 10.1186/s41181-023-00212-4. EJNMMI Radiopharm Chem. 2023. PMID: 37821747 Free PMC article.
Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment.
Żuk M, Podgórski R, Ruszczyńska A, Ciach T, Majkowska-Pilip A, Bilewicz A, Krysiński P. Żuk M, et al. Among authors: majkowska pilip a. Pharmaceutics. 2022 Aug 12;14(8):1680. doi: 10.3390/pharmaceutics14081680. Pharmaceutics. 2022. PMID: 36015306 Free PMC article.
Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter 213Bi.
Cytryniak A, Żelechowska-Matysiak K, Nazaruk E, Bilewicz R, Walczak R, Majka E, Mames A, Bruchertseifer F, Morgenstern A, Bilewicz A, Majkowska-Pilip A. Cytryniak A, et al. Among authors: majkowska pilip a. Mol Pharm. 2022 Aug 1;19(8):2818-2831. doi: 10.1021/acs.molpharmaceut.2c00182. Epub 2022 Jul 18. Mol Pharm. 2022. PMID: 35849547 Free PMC article.
Innovative radioisotope therapy for patients with neuroendocrine tumors using an α (225Ac) emitter labeled somatostatin analog: octreotate. A promising new treatment for advanced progressive neuroendocrine neoplasms.
Budlewski T, Król ZJ, Bruchertseifer F, Majkowska-Pilip A, Morgenstern A, Wierzba W. Budlewski T, et al. Among authors: majkowska pilip a. Pol Arch Intern Med. 2022 Aug 22;132(7-8):16275. doi: 10.20452/pamw.16275. Epub 2022 Jun 13. Pol Arch Intern Med. 2022. PMID: 35699734 Free article. No abstract available.
27 results